Dermagnostix develops molecular diagnostic tests for skin diseases (Healthcare Industry BW)
Dermagnostix GmbH has developed a rapid test to differentiate between psoriasis and eczema. This test is currently undergoing preclinical testing, with market launch planned for 2023.